Literature DB >> 20948981

Therapy Operating Characteristic (TOC) Curves and their Application to the Evaluation of Segmentation Algorithms.

Harrison H Barrett1, Donald W Wilson, Matthew A Kupinski, Kasarachi Aguwa, Lars Ewell, Robert Hunter, Stefan Müller.   

Abstract

This paper presents a general framework for assessing imaging systems and image-analysis methods on the basis of therapeutic rather than diagnostic efficacy. By analogy to receiver operating characteristic (ROC) curves, it utilizes the Therapy Operating Characteristic or TOC curve, which is a plot of the probability of tumor control vs. the probability of normal-tissue complications as the overall level of a radiotherapy treatment beam is varied. The proposed figure of merit is the area under the TOC, denoted AUTOC. If the treatment planning algorithm is held constant, AUTOC is a metric for the imaging and image-analysis components, and in particular for segmentation algorithms that are used to delineate tumors and normal tissues. On the other hand, for a given set of segmented images, AUTOC can also be used as a metric for the treatment plan itself. A general mathematical theory of TOC and AUTOC is presented and then specialized to segmentation problems. Practical approaches to implementation of the theory in both simulation and clinical studies are presented. The method is illustrated with a a brief study of segmentation methods for prostate cancer.

Entities:  

Year:  2010        PMID: 20948981      PMCID: PMC2952955          DOI: 10.1117/12.844189

Source DB:  PubMed          Journal:  Proc SPIE Int Soc Opt Eng        ISSN: 0277-786X


  14 in total

1.  Intensity-modulated radiation therapy: a clinical perspective. Introduction.

Authors:  Avraham Eisbruch
Journal:  Semin Radiat Oncol       Date:  2002-07       Impact factor: 5.934

Review 2.  The IMRT information process-mastering the degrees of freedom in external beam therapy.

Authors:  Anders Ahnesjö; Björn Hårdemark; Ulf Isacsson; Anders Montelius
Journal:  Phys Med Biol       Date:  2006-06-20       Impact factor: 3.609

3.  Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models.

Authors:  Matthias Söhn; Di Yan; Jian Liang; Elisa Meldolesi; Carlos Vargas; Markus Alber
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-01-26       Impact factor: 7.038

4.  A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy.

Authors:  Hiram A Gay; Andrzej Niemierko
Journal:  Phys Med       Date:  2007-09-07       Impact factor: 2.685

Review 5.  Report of the AAPM Task Group No. 105: Issues associated with clinical implementation of Monte Carlo-based photon and electron external beam treatment planning.

Authors:  Indrin J Chetty; Bruce Curran; Joanna E Cygler; John J DeMarco; Gary Ezzell; Bruce A Faddegon; Iwan Kawrakow; Paul J Keall; Helen Liu; C M Charlie Ma; D W O Rogers; Jan Seuntjens; Daryoush Sheikh-Bagheri; Jeffrey V Siebers
Journal:  Med Phys       Date:  2007-12       Impact factor: 4.071

Review 6.  Image-based modeling of normal tissue complication probability for radiation therapy.

Authors:  Joseph O Deasy; Issam El Naqa
Journal:  Cancer Treat Res       Date:  2008

Review 7.  Current status of intensity-modulated radiation therapy (IMRT).

Authors:  Kazuo Hatano; Hitoshi Araki; Mitsuhiro Sakai; Takashi Kodama; Naoki Tohyama; Tohru Kawachi; Masaharu Imazeki; Takayuki Shimizu; Tsutomu Iwase; Minoru Shinozuka; Hideyo Ishigaki
Journal:  Int J Clin Oncol       Date:  2007-12-21       Impact factor: 3.402

8.  Technical note: dose-volume histogram analysis in radiotherapy using the Gaussian error function.

Authors:  James C L Chow; Daniel Markel; Runqing Jiang
Journal:  Med Phys       Date:  2008-04       Impact factor: 4.071

Review 9.  Three-dimensional conformal radiotherapy and dose escalation: where do we stand?

Authors:  M J Zelefsky; S A Leibel; G J Kutcher; Z Fuks
Journal:  Semin Radiat Oncol       Date:  1998-04       Impact factor: 5.934

10.  A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets.

Authors:  Brad Warkentin; Pavel Stavrev; Nadia Stavreva; Colin Field; B Gino Fallone
Journal:  J Appl Clin Med Phys       Date:  2004-01-01       Impact factor: 2.102

View more
  7 in total

1.  Objective assessment of image quality VI: imaging in radiation therapy.

Authors:  Harrison H Barrett; Matthew A Kupinski; Stefan Müeller; Howard J Halpern; John C Morris; Roisin Dwyer
Journal:  Phys Med Biol       Date:  2013-11-21       Impact factor: 3.609

2.  Objective assessment of the effects of tumor motion in radiation therapy.

Authors:  Yijun Ding; Harrison H Barrett; Matthew A Kupinski; Yevgeniy Vinogradskiy; Moyed Miften; Bernard L Jones
Journal:  Med Phys       Date:  2019-06-07       Impact factor: 4.071

3.  Therapy operating characteristic curves: tools for precision chemotherapy.

Authors:  Harrison H Barrett; David S Alberts; James M Woolfenden; Luca Caucci; John W Hoppin
Journal:  J Med Imaging (Bellingham)       Date:  2016-05-02

4.  Quantifying and Reducing Uncertainties in Cancer Therapy.

Authors:  Harrison H Barrett; David S Alberts; James M Woolfenden; Zhonglin Liu; Luca Caucci; John W Hoppin
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-02-21

5.  Task-based image quality assessment in radiation therapy: initial characterization and demonstration with computer-simulation study.

Authors:  Steven R Dolly; Yang Lou; Mark A Anastasio; Hua Li
Journal:  Phys Med Biol       Date:  2019-07-18       Impact factor: 3.609

6.  Physiological random processes in precision cancer therapy.

Authors:  Nick Henscheid; Eric Clarkson; Kyle J Myers; Harrison H Barrett
Journal:  PLoS One       Date:  2018-06-29       Impact factor: 3.240

7.  A Bayesian approach to tissue-fraction estimation for oncological PET segmentation.

Authors:  Ziping Liu; Joyce C Mhlanga; Richard Laforest; Paul-Robert Derenoncourt; Barry A Siegel; Abhinav K Jha
Journal:  Phys Med Biol       Date:  2021-06-14       Impact factor: 3.609

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.